Fibromyalgia: principles of diagnostics and complex therapy


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The review presents data on the etiology and pathogenesis of fibromyalgia, its clinical manifestations, current diagnostic criteria and recommendations for therapy based on the principles of evidence-based medicine. In the section, devoted to the treatment of the disease, both non-drug and drug methods with a high degree of evidence are considered in details. The proven effectiveness of multidisciplinary therapeutic programs suggests that the combination of medicamentous treatment, physical exercises and cognitive-behavioral component is the method of choice for treating all patients with fibromyalgia.

全文:

受限制的访问

作者简介

Andrey Danilov

I.M. Sechenov First Moscow State Medical University FSAEI of HE of the Ministry of Health of Russia (Sechenov University)

Email: nervkafedra@gmail.com
MD, Professor of the Department of nervous diseases of the Institute Of Professional Education

参考

  1. Данилов А.Б. Фибромиалгия: новые возможности терапии. РМЖ. 2010; 18(16): 998-1003.
  2. Иваничев Г. А., Старосельцева Н. Г. Миофасциальный генерализованный болевой (фибромиалгический) синдром. Казань, 2002. 162 с.
  3. Калягин А.Н. Современные диагностические подходы при фибромиалгии. Современная ревматология. 2012; 1: 11-14.
  4. Колоколов О.В., Ситкали И.В., Шахпазов С.Ж., Колоколова А.М. Синдром хронической распространенной боли -новая междисциплинарнаяпроблема или компетенция врача общей практики. Фарматека. 2018; 5: 71-80.
  5. Табеева Г.Р., Короткова С.Б. Фибромиалгия (обзор). Журнал невропатологии и психиатрии им. Корсакова. 2000; 100(4): 69-77.
  6. Чичасова Н.В. Первичная фибромиалгия: клинические проявления, диагностика, лечение. Терапевтический архив. 1994; 66(1 1): 89-92.
  7. Arnold L.M., Rosen A., Pritchett Y.L.et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005; 119(1-3): 5-15.
  8. Arnold L.M., Goldenberg D.L., Stanford S.B. et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum. 2007; 56 (4): 1336-44.
  9. Arnold L.M., Russell I.J., Diri E.W. et al. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain. 2008; 9: 792-805.
  10. Bennett M.I., Tai Y.M. Intravenous lidocaine in the management of primary fibromyalgia syndrome. Int J Clin Pharmacol Res. 1995; 15(3): 115-9.
  11. Bennett R.M., Kamin M., Karim R. et al. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebocontrolled study. Am J Med. 2003; 114(7): 537-45.
  12. Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol. 2005; 23(5): S154-62.
  13. Borchers A.T., Gershwin M.E. Fibromyalgia: A Critical and Comprehensive. Review. Clin. Rev. Allergy Immunol. 2015; 49: 100-51.
  14. Choy E.H.S., Mease P.J., Kajdasz D.K. et al. Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials. Clin Rheumatol 2009; 28(9): 1035-44.
  15. Crofford L.J., Rowbotham M.C., Mease P.J. et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double- blind, placebo-controlled trial. Arthritis Rheum. 2005; 52(4): 1264-73.
  16. Crofford L.J., Mease P.J., Simpson S.L. et al. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-months, double-blind, placebo-controlled trial with pregabalin. Pain. 2008; 136: 419-31.
  17. Grayston R., Czanner G., Elhadd K. et. al. A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: Implications for a new paradigm in fibromyalgia etiopathogenesis. Seminars in Arthritis and Rheumatism. 2018 Aug 23. pii: S0049-0172(18)30363-9.
  18. Hauser W., Bernardy K., Uceyler N. et al. Treatment of fibromyalgia syndrome with gabapentin and pregabalin: a metaanalysis of randomized controlled trials. Pain. 2009; 145(1-2): 69-81.
  19. Hauser W., Bernardy K., Uceyler N. et al. Treatment of fibromyalgia syndrome with antidepressants: a metaanalysis. JAMA. 2009; 301(2): 198-209.
  20. Häuser W., Fitzcharles M.A. Facts and myths pertaining to fibromyalgia. Dialogues Clin Neurosci. 2018 Mar; 20(1): 53-62.
  21. Jones K.D., Adams D., Winters-Stone K. et al. A comprehensive review of 16 exercise treatment studies in fibromyalgia (1988-2005). Health Qual Life Outcomes. 2006; 4: 67-73.
  22. Macfarlane G. et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. doi:10.1136/ annrheumdis-2016-209724.
  23. Mease P.J., Clauw D.J., Gendreau R.M. et al. The efficacy and safety of milnacipran for treatment of fibromyalgia: a randomized, double- blind, placebo-controlled trial. J Rheumatol. 2009; 36 (2): 398-409.
  24. Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol. 2005; 32 Suppl. 75: 6-21.
  25. Mease P.J., Russell I.J., Arnold L.M. et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol. 2008; 35: 502-514.
  26. Smythe H.A., Moldofsky H. Two contributions to understanding of the «fibrositis» syndrome. Bull Rheum Dis. 1977; 28: 928-931.
  27. Staud R., Weyl E.E., Bartley E., Price D.D., Robinson M.E. Analgesic and anti-hyperalgesic effects of muscle injections with lidocaine or saline in patients with fibromyalgia syndrome. Eur J Pain. 2014 Jul; 18(6): 803-12.
  28. Staud R., Nagel S., Robinson M.E. et al. Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled trial. Pain. 2009; 145: 96-104.
  29. Straube S., Derry S., Moore R., McQuay H. Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports. Rheumatology. 2010; 49: 706-715.
  30. Talotta R., Bazzichi L., Di Franco M. One year in review 2017: fibromyalgia. Clin Exp Rheumatol. 2017; 35 (Suppl. 105): S6-S12.
  31. Vitton O., Gendreau M., Gendreau J. et al. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol. 2004; 19 Suppl. 1: S27-35.
  32. Wolfe F., Smythe H.A., Yunus M.B. et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum. 1990; 33(2): 160-72.
  33. Wolf F., Clauw D.J., Fitzcharles M.-A. et al. The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom. Severity. Arthr Care Res. 2010; 62(5): 600-17.
  34. Wolfe F., Clauw D.J., Fitzcharles M.A. et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J. Rheum. 2011; 38(6): 1113-22.
  35. Wolfe F., Fitzcharles M.A., Goldenberg D.L. et al. Comparison of Physician-Based and Patient-Based Criteria for the Diagnosis of Fibromyalgia. Arthr. Care Res. (Hoboken). 2016; 68(5): 652-59.
  36. Zijlstra T.R., Barendregt P.J., van de Laar MA. Venlafaxine in fibromyalgia: results of a randomized, placebo-controlled, double-blind trial [abstract]. Arthritis Rheum 2002; 46: S105.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2018
##common.cookie##